FDA Investigator Anthony J Ladner
Anthony J Ladner has conducted inspections on 54 sites in 3 countries as of 01 Mar 2022. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
54
Last Inspection Date:
01 Mar 2022
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India,
Canada
FDA Investigators that have inspected at least one site in common with Anthony J Ladner:
Abby E Pelletier,
Aerial A Smith,
Aimee J Edwin,
Alan A Rivera,
Alan M Barker,
Albert L Nguyen,
Alecia L Marson,
Alicia M Mozzachio,
Allen F Hall,
Amy L Mcintyre,
Ana M Placencia,
Anders W Evenson,
Angelica M Hernandez,
April L Brown,
April L Young,
Arsen Karapetyan,
Azza Talaat,
Barbara M Frazier,
Beatrix D Arevalo,
Beatrix D Hippe,
Bei Y He,
Benjamin W Anderson,
Bonita S Chester,
Bradley A Servais,
Brenda W Uratani, PhD,
Brett R Havranek,
Bryan L Mcguckin,
Carolyn A Warren,
Charles L Zhou,
Charles M Edwards,
Charles R Cote, RIC,
Cheryl A Clausen,
Christopher D Leach,
Concepcion Cruz, Jr,
Courtney R Ingalsbe,
Courtney R Tiegs,
Dacia E Quick,
Dale A Nyberg,
Danial S Hutchison,
Daniel J Roberts,
Daniel L Aisen,
David A Oluwo,
David B Wieneke,
Denise L Burosh,
Denise M Digiulio,
Dennis Cantellops Paite,
Dipesh K Shah,
Edward M James,
Emilie E Kahn,
Emily E Markgraf,
Eric M Mueller, PharmD,
Eric S Myskowski,
Erika V Butler,
Fannie M Harrell,
Felix Maldonado,
Grant M Ruis,
Gregory A Berg,
Gregory W Smith,
Guo Q Shen,
Gwyn G Dickinson,
Howard A Burmester,
Ivan E Reyes,
Ivis L Negron,
J Benedict,
Jacob W Reynolds,
James K Ireland,
Janis R Armedoriz,
Jasjeet K Sekhon,
Jeanne D Shaffer,
Jeanne M Morris,
Jeffry A Bernhardt,
Jennifer A Longie Vollom,
Jennifer Al Vollon,
Jennifer S Ness,
Joel D Hustedt,
Joel D Martinez,
John E Emmert,
Jonathan G Gayechuway,
Jonathan G Swoboda,
Jonathan L Blonk,
Jose A Lopez,
Joseph A Piechocki,
Joseph R Lambert,
Justin A Boyd,
Kellie L Thommes, RN,
Kellie L Westerbuhr,
Kenneth A Libertoski,
Kenneth H Williams,
Kevin P Regan,
Krista K Petersen,
Kristy E Zuroski,
Ladner Ladner, Anthony J,
Lauren E Sanger,
Lequita M Mayhew,
Linda V Weyer,
Lisa L Flores,
Lisa M Lopez,
Logan T Williams,
Lori B Wikstrom,
Lucas B Leake,
M Edith Snyder,
Margaret L Bolte,
Marie A Fadden,
Marissa S Henning,
Marissa S Steinhagen,
Matthew B Casale,
Meisha R Sampson,
Meisha Waters,
Melissa I Michurski,
Melissa M Steiger,
Michael A Taylor,
Michael E Cimaglio,
Michele Perry Williams,
Minerva Rogers,
Monica E Murie,
Muralidhara B Gavini, PhD,
Nadine Nanko Johnson,
Nathan B Davis,
Nicole C Victoria, PhD,
Nicole E Knowlton,
Norman K Starks,
Pankaj H Amin,
Patrick B Cummings,
Peter T Erlandson,
Pratik S Upadhyay, DDC,
Rafeeq A Habeeb,
Ralph Jerndal,
Rebecca L Caulfield,
Robert J Ham,
Robert J Martin,
Ross J Grigsby,
Sandra A Hughes,
Sandra D Wilson,
Sandra Sejdinovic,
Scott A Golladay,
Scott B Laufenberg,
Sean R Marcsisin,
Sharon K Thoma, PharmD,
Sharon L Matson,
Soyinka S Eneng,
Susan M Matthias,
Tamara J Umscheid,
Tenzin Jangchup,
Terrance L Scheiber,
Timothy R Marrs,
Ucheabuchi Cchudi Nwankwor,
Victoria A Wagoner,
Warren J Lopicka,
William A Warnick,
William E Keer,
William J Leonard,
Yiyue Zhang (nmi), PhD
Anthony J Ladner's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more